Nurses have a pivotal role to play in the widespread implementation and adoption of digital health technologies throughout the healthcare sector for the primary purpose of improving safety and quality of patient care.
Australian Health Journal talked with two of Australian top leaders in nursing and in digital health on how the role of nursing is pivotal to the success of digital health in the Australian health system.
Firstly, Adjunct Professor Kylie Ward, CEO of Australian College of Nursing (ACN) spoke about the ACN Nurse Informatics and Digital Health Faculty bringing together a group of nurses with a common interest in nursing informatics and digital health technologies. The faculty members work together to solve problems, share knowledge, cultivate best practice and foster innovation in this important area of healthcare. Kylie stresses, “The more that the digital platforms can assist nurses to spend time educating supporting, monitoring and investing in the people that they serve, the more enabled and empowered they are to do their job.”
Also in the joint interview, Amanda Cattermole, CEO of the Australian Digital Health Agency (ADHA) spoke about how, “Nurses have been great early adopters of digital health technologies. The uptake being driven further during COVID”. The ADHA provides information to help clinician digital health literacy through webinars, face to face meetings, education supports and tools, as well as the colleges and peak organisations across the sector for their workforces.
Kylie pointed out, even with digital health technologies there is an important role nurses play with their intuition, intellect and the heart. None of these can be automated. However the success of digital health is also down to the inclusion of nurses and nursing leadership in the design and co-design of digital health tools in the future. Amanda added, “This includes the structured learning and in the moment learning on the job. “
You Might also like
-
Significant funding announced for NSW biomedical researchers
The Snow Medical Research Foundation (Snow Medical) has announced a new $24 million investment in three outstanding Australian biomedical researchers through its prestigious Snow Fellowships.
These Fellows will tackle major global health challenges spanning autoimmune disease, neurological disorders, and genetic disease. Their work addresses conditions that disproportionately affect vulnerable and underserved populations, including First Nations communities, while advancing precision medicine and translational care. Collectively, their research aims to deliver safer vaccines, better diagnostics, and more equitable genomic and neurological healthcare.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
Australian Healthcare Week
Held 27th-28th March at the ICC Sydney, the expo is one of the largest, if not the largest healthcare events in the regions. AHJ as media partner attended and met with delegates, exhibitors and leaders in the healthcare industry. Click the post to see footage.